Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)

MarketResearchReports.Biz announces addition of new report “Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” to its database. Visit: http://www.marketresearchreports.biz/analysis-details/global-cardiac-bio-implant-devices-implantable-cardioverter-defibrillators-implantable-cardiac-pacemakers-heart-valve-coronary-stent-peripheral-stent-ventricular-assist-device-market-forecast-clinical-trials-manda

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketResearchReports.biz

MarketResearchReports.biz

Albany, NY (PRWEB) July 21, 2013

The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term growth opportunities for manufacturers operating in the market.

To Read The Complete Report with TOC: http://www.marketresearchreports.biz/analysis-details/global-cardiac-bio-implant-devices-implantable-cardioverter-defibrillators-implantable-cardiac-pacemakers-heart-valve-coronary-stent-peripheral-stent-ventricular-assist-device-market-forecast-clinical-trials-manda

Renub Research study titled “Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market. This 284 page report with 258 Figures and 24 Tables studies the Global Cardiac Implant Device Market. This report contains 24 chapters and has been bifurcate into 10 segments.

i) Worldwide Cardiac Implants Device Analysis (Chapter 2)
ii) Implantable Cardioverter Defibrillators (ICD) (Chapter 3 to 5)
iii) Implantable Cardiac Pacemakers (ICP) (Chapter 6 to 8)
iv) Heart Valve (Chapter 9 to 11)
v) Coronary Stent (Chapter 12 to 15)
vi) Perpheral Stent (Chapter 16 to 17)
vii) Ventricular Assist Device (Chapter 18 to 20)
viii) Cardiac Implants Devices Clinical Trial Statement (Chapter 21)
ix) Merger & Acquisitions (Chapter 22)
x) Growth Drivers & Challenges (Chapter 22 to 24)

Browse All The Report Of This Publisher Visit: http://www.marketresearchreports.biz/publisher/31

All the above segments have been further sub divided into

a) Market & Forecast (2008 - 2017)
b) Sales Unit & Forecast (By Volume) (2008 - 2017)
c) Market Share & Forecast (2008 - 2017)
d) Companies Market Share & Forecast(2008 - 2017)
e) Companies Revenue & Forecast (2008 - 2017)
f) Clinical Trial Statement
g) Merger & Acquisition
h) Growth Driver & Challenges

The Following 24 Chapters Contains

  •     First chapter is Executive Summary.
  •     Second chapter contains worldwide cardiac implants device market, market share & forecast (2010 – 2017).
  •     Third to Fifth chapter contains implantable cardioverter defibrillators (ICD) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).
  •     Sixth to Eighth chapter contains implantable cardiac pacemakers (ICP) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).
  •     Ninth to Eleventh chapter contains heart valve (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2009-2017).
  •     Twelfth to Fifteenth chapter contains coronary stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008-2017).
  •     Sixteenth to Seventeenth chapter contains peripheral stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).
  •     Eighteenth to nineteenth chapter contains ventricular assist device (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).
  •     Twentieth to Twenty Three chapters contains clinical trial statement, merger & acquisition, growth driver & challenges.

For Market Research Reports Visit – http://mresearchreports.blogspot.com/

Table of Contents

1. Executive Summary

2. Worldwide Cardiac Implants Device Analysis (2010 – 2017)
2.1 Worldwide – Cardiac Implants Device Market & Forecast
2.2 Worldwide – Cardiac Implants Device Market Share & Forecast

3. Implantable Cardioverter Defibrillators (ICD) Analysis (2008 – 2017)
3.1 Worldwide – ICD Market & Forecast
3.2 Worldwide – ICD Sales Unit & Forecast (By Volume)
3.3 USA vs. Rest of World – ICD Market Share & Forecast
3.4 Companies (Boston Scientific, St Jude Medical, Medtronic & Others) – ICD Market Share & Forecast

4. Implantable Cardioverter Defibrillators (ICD) Market, Volume & Forecast – USA & ROW (2008 – 2017)
4.1 United States – ICD Market & Forecast
4.2 United States – ICD Sales Unit & Forecast (By Volume)
4.3 Rest of the World (ROW) – ICD Market & Forecast
4.4 Rest of the World (ROW) – ICD Sales Unit & Forecast (By Volume)

To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis/168251

5. Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast – Companies Analysis (2008 – 2017)
5.1 Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.1.1 Worldwide – Boston Scientific ICD Revenue & Forecast
5.1.2 United States – Boston Scientific ICD Revenue & Forecast
5.1.3 Rest of the World – Boston Scientific ICD Revenue & Forecast
5.2 St Jude Medical Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.2.1 Worldwide – St Jude Medical ICD Revenue & Forecast
5.2.2 United States – St Jude Medical ICD Revenue & Forecast
5.2.3 Rest of the World – St Jude Medical ICD Revenue & Forecast
5.3 Medtronic Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.3.1 Worldwide – Medtronic ICD Revenue & Forecast
5.3.2 United States – Medtronic ICD Revenue & Forecast
5.3.3 Rest of the World – Medtronic ICD Revenue & Forecast
5.4 Other Companies Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.4.1 Worldwide – Other Companies ICD Revenue & Forecast
5.4.2 United States – Other Companies ICD Revenue & Forecast
5.4.3 Rest of the World – Other Companies ICD Revenue & Forecast

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Website: http://www.marketresearchreports.biz/
Blog: http://mrrbizmintel.blogspot.com/
Blog: http://marketsbuzz.wordpress.com/